We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Real-world research offers the potential to better understand a medicine’s value in a clinical setting, but to fully harness its potential, drugmakers will need to restructure the way they think. Read More
Sanofi and AstraZeneca are touting an innovative, open model of collaboration that will see the direct exchange of 210,000 compounds between the two companies’ proprietary libraries. Read More
Roche subsidiary Genentech will exercise its option to commercialize Ophthotech’s wet age-related macular degeneration drug Fovista with Novartis outside the U.S. Read More
French drugmaker Sanofi is looking to future-proof its diabetes franchise by in-licensing rights to a trio of next-generation diabetes medicines from South Korea’s Hanmi in a deal worth up to $4.2 billion. Read More